Illinois General Assembly - Bill Status for SB2672
Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

 Bill Status of SB2672  103rd General Assembly


Short Description:  INS CD-GENERIC DRUG SHORTAGE

Senate Sponsors
Sen. Laura M. Murphy - Julie A. Morrison, Mary Edly-Allen, Adriane Johnson, Doris Turner, Emil Jones, III, Christopher Belt and Robert F. Martwick

House Sponsors
(Rep. Terra Costa Howard)

Last Action
DateChamber Action
  4/12/2024HouseReferred to Rules Committee

Statutes Amended In Order of Appearance
215 ILCS 5/356z.71 new
215 ILCS 125/5-3from Ch. 111 1/2, par. 1411.2
215 ILCS 130/4003from Ch. 73, par. 1504-3
215 ILCS 165/10from Ch. 32, par. 604
305 ILCS 5/5-16.8


Synopsis As Introduced
Amends the Accident and Health Article of the Illinois Insurance Code. Provides that if a generic drug is unavailable due to a supply issue and dosage cannot be adjusted, a group or individual policy of accident and health insurance or a managed care plan that is amended, delivered, issued, or renewed after January 1, 2025 shall provide coverage for a brand name eligible prescription drug until supply of the generic drug is available. Defines "eligible prescription drug" and "generic drug". Makes conforming changes in the Health Maintenance Organization Act, the Limited Health Service Organization Act, the Voluntary Health Services Plans Act, and the Medical Assistance Article of the Illinois Public Aid Code.

Senate Committee Amendment No. 1
Replaces everything after the enacting clause. Reinserts the provisions of the introduced bill with the following changes. Adds a definition of "unavailable". Provides that if a generic drug or a therapeutic equivalent is unavailable (rather than if a generic drug is unavailable) due to a supply issue and dosage cannot be adjusted, a group or individual policy of accident and health insurance or a managed care plan that is amended, delivered, issued, or renewed after January 1, 2026 (instead of January 1, 2025) shall provide coverage for a brand name eligible prescription drug until supply of the generic drug or a therapeutic equivalent is available.

Actions 
DateChamber Action
  1/10/2024SenateFiled with Secretary by Sen. Laura M. Murphy
  1/10/2024SenateFirst Reading
  1/10/2024SenateReferred to Assignments
  1/31/2024SenateAssigned to Insurance
  2/1/2024SenateAdded as Chief Co-Sponsor Sen. Julie A. Morrison
  2/22/2024SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Laura M. Murphy
  2/22/2024SenateSenate Committee Amendment No. 1 Referred to Assignments
  2/28/2024SenateSenate Committee Amendment No. 1 Assignments Refers to Insurance
  3/6/2024SenateSenate Committee Amendment No. 1 Adopted
  3/6/2024SenateDo Pass as Amended Insurance; 007-000-000
  3/6/2024SenatePlaced on Calendar Order of 2nd Reading March 7, 2024
  4/10/2024SenateSecond Reading
  4/10/2024SenatePlaced on Calendar Order of 3rd Reading April 11, 2024
  4/11/2024SenateThird Reading - Passed; 059-000-000
  4/11/2024SenateAdded as Co-Sponsor Sen. Mary Edly-Allen
  4/11/2024SenateAdded as Co-Sponsor Sen. Adriane Johnson
  4/11/2024SenateAdded as Co-Sponsor Sen. Doris Turner
  4/11/2024SenateAdded as Co-Sponsor Sen. Emil Jones, III
  4/11/2024SenateAdded as Co-Sponsor Sen. Christopher Belt
  4/11/2024HouseArrived in House
  4/12/2024HouseChief House Sponsor Rep. Terra Costa Howard
  4/12/2024HouseFirst Reading
  4/12/2024HouseReferred to Rules Committee
  4/12/2024SenateAdded as Co-Sponsor Sen. Robert F. Martwick

Back To Top